PAPER May M, Hardin WB
SEARCH RESULTS
330026 RESULTS
PAPER Willson RA, Chapman BJ, Munday KA
The effect of hypothermia (25 degrees C) on the circulatory system of the rat.
Comp Biochem Physiol A Comp Physiol. 1976 Jan 1;54(1):135-9. PubMed: 3336PAPER Klechikov VZ, Ramzaev VP
[Possibilities and various results of the use of contact microscopy in pathological practice].
Arkh Patol. 1978 Jan 1;40(10):72-4. PubMed: 83859PAPER Goette DK, Odom RB
Allergic contact dermatitis to topical fluorouracil.
Arch Dermatol. 1977 Aug 1;113(8):1058-61. PubMed: 889334PAPER Kasvinsky PJ, Meyer WL
The effect of pH and temperature on the kinetics of native and altered glycogen phosphorylase.
Arch Biochem Biophys. 1977 Jun 1;181(2):616-31. PubMed: 20052PAPER Freuchen I, Ostergaard J
[Flunitrazepam (Rohypnol) as evening premedication. Report of a controlled clinical comparison with nitrazepam (Mogadon) and allypropymal].
Ugeskr Laeger. 1976 Sep 6;138(37):2232-4. PubMed: 9717PAPER Kautu BB, Carrasquilla A, Hicks ML, Caldwell KA, Caldwell GA
Valproic acid ameliorates C. elegans dopaminergic neurodegeneration with implications for ERK-MAPK signaling.
Neurosci Lett. 2013 Apr 29;541:116-9. PubMed: 23485787PAPER Mukhamedyarov MA, Rizvanov AA, Safiullov ZZ, Izmailov AA, Sharifullina GA, Solovieva VV, Fedotova VY, Salafutdinov II, Cherenkova EE, Bashirov FV, Kaligin MS, Abdulkhakov SR, Shmarov MM, Logunov DY, Naroditsky BS, Kiyasov AP, Zefirov AL, Islamov RR
Analysis of the efficiency of gene-cell therapy in transgenic mice with amyotrophic lateral sclerosis phenotype.
Bull Exp Biol Med. 2013 Feb;154(4):558-61. PubMed: 23486603PAPER Jeppsson A, Zetterberg H, Blennow K, Wikkelsø C
Idiopathic normal-pressure hydrocephalus: pathophysiology and diagnosis by CSF biomarkers.
Neurology. 2013 Apr 9;80(15):1385-92. PubMed: 23486875PAPER Kontush A, Schekatolina S
An update on using vitamin E in Alzheimer's disease.
Expert Opin Drug Discov. 2008 Feb;3(2):261-71. PubMed: 23480224PAPER Kimiskidis VK, Papaliagkas VT
Event-related potentials for the diagnosis of mild cognitive impairment and Alzheimer's disease.
Expert Opin Med Diagn. 2012 Jan;6(1):15-26. PubMed: 23480617PAPER Kozauer N, Katz R
Regulatory innovation and drug development for early-stage Alzheimer's disease.
N Engl J Med. 2013 Mar 28;368(13):1169-71. Epub 2013 Mar 13 PubMed: 23484795PAPER Wittwer JE, Webster KE, Hill K
Reproducibility of gait variability measures in people with Alzheimer's disease.
Gait Posture. 2013 Feb 25; PubMed: 23485356PAPER Penna I, Vassallo I, Nizzari M, Russo D, Costa D, Menichini P, Poggi A, Russo C, Dieci G, Florio T, Cancedda R, Pagano A
A novel snRNA-like transcript affects amyloidogenesis and cell cycle progression through perturbation of Fe65L1 (APBB2) alternative splicing.
Biochim Biophys Acta. 2013 Jun;1833(6):1511-26. PubMed: 23485396PAPER Huang Y, Li T, Eatherton A, Mitchell WL, Rong N, Ye L, Yang XJ, Jin S, Ding Y, Zhang J, Li Y, Wu Y, Jin Y, Sang Y, Cheng Z, Browne ER, Harrison DC, Hussain I, Wan Z, Hall A, Lau LF, Matsuoka Y
Orally bioavailable and brain-penetrant pyridazine and pyridine-derived γ-secretase modulators reduced amyloidogenic Aβ peptides in vivo.
Neuropharmacology. 2013 Jul;70:278-86. PubMed: 23485401Current Filters
No filters selected